Powered by BiozThis cell line is a modified version of WIBR3, engineered to contain a homozygous Q129X mutation for PTEN-induced putative kinase. This mutation is involved in early onset Parkinson’s Disease (PD) and is autosomal recessive.
- Cell Line Alias WIBR3_PINK1_Q129X_C4-1
- Unit of Measure (UOM) vial
- Cell Type Modified Human ES
- Sex Female
- Genetic Alteration Mutation Information PINK1 Q129X, NP_115785.1, p.Q129X/p.Q129X
- Genetic Modification Keyword Isogenic - Parkinson's Disease
- Disease Parkinson's disease
- Genetic Alteration Mutation PINK1
- hPSCReg ID WIBRe001-A-11
- NIH Approval NIHhESC-10-0079
- Provider University of California, Berkeley
- Collections iSCORE-PD: Isogenic Stem Cell Collection to Research Parkinson’s Disease
| Lot Number | Culture Platform | Lot Description | Banked By | Passage Number | Protocol | Product Information & Testing |
| WB68996 | iSCORE 01 medium / 2x CF1 MEF | WiCell | 33 | WiCell Feeder Based (MEF) Protocol 01 for Culture of MJFF iSCORE Lines |